AUSTIN, Texas — Drugs known as HDAC inhibitors may prove useful in treating post-traumatic stress disorder (PTSD), according to a study conducted by faculty at The University of Texas at Austin's Waggoner Center for Alcohol and Addiction Research.
The study, the results of which were recently published in Neuropsychopharmacology, may point the way toward new treatments for PTSD, a severe anxiety disorder which is estimated to afflict as many as one in eight returning Iraq and Afghanistan War veterans.
"The HDAC inhibitors are already being used in clinical trials, but in relation to other neurological diseases, like Alzheimer's and Huntington's," says Igor Ponomarev, a research assistant professor in the College of Pharmacy and the Waggoner Center. "They've never been tested in PTSD. The results of this study suggest that they should be." …
Scientists Identify New Approaches to Treating PTSD | The University of Texas at Austin
No comments:
Post a Comment